Krishnamurthy R, Belenje A, Senthil S, Rani PK. Limited transscleral cyclophotocoagulation for silicone oil-induced glaucoma in eyes with good visual potential. World J Clin Cases 2026; 14(21): 121479 [DOI: 10.12998/wjcc.121479]
Corresponding Author of This Article
Padmaja Kumari Rani, MS, FRCS, Network Associate Director, Teleophthalmology, Srimati Kannuri Santhamma Centre for Vitreo-Retinal Diseases, Anant Bajaj Retina Institute, L V Prasad Eye Institute, Banjara Hills, Hyderabad 500034, India. rpk@lvpei.org
Research Domain of This Article
Ophthalmology
Article-Type of This Article
research-article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Krishnamurthy R, Belenje A, Senthil S, Rani PK. Limited transscleral cyclophotocoagulation for silicone oil-induced glaucoma in eyes with good visual potential. World J Clin Cases 2026; 14(21): 121479 [DOI: 10.12998/wjcc.121479]
Rashmi Krishnamurthy, Sirisha Senthil, Kalathur Venugopal Reddy Glaucoma Institute, L V Prasad Eye Institute, Hyderabad 500034, India
Akash Belenje, Padmaja Kumari Rani, Srimati Kannuri Santhamma Centre for Vitreo-Retinal Diseases, Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad 500034, India
Author contributions: Krishnamurthy R and Belenge A conducted the research; Krishnamurthy R drafted the manuscript; Krishnamurthy R and Rani PK designed the study, analyzed the data; Senthil S and Rani PK critically reviewed and revised the manuscript; and all authors read and approved the final manuscript.
AI contribution statement: The authors assume full responsibility and accountability for the integrity, accuracy, originality, and scientific validity of the manuscript and all submitted materials. We confirm that AI tools were not used during manuscript preparation.
Supported by Hyderabad Eye Research Foundation.
Institutional review board statement: This study was approved by the Medical Ethics Committee of L V Prasad Eye Institute, approval No. LEC-BHR-R-03-2026-394.
Informed consent statement: Due to the retrospective nature of this study and the de-identified nature of the data, involving minimal risk of identification, informed consent was deemed unnecessary by the local Ethics Committee.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Data is available from the corresponding author upon reasonable request to: Padmaja Kumari Rani, MS, Head, Network Associate Director, Teleophthalmology (LVPEI network) Consultant, Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Banjara Hills, Hyderabad 500034, India or rpk@lvpei.org.
Corresponding author: Padmaja Kumari Rani, MS, FRCS, Network Associate Director, Teleophthalmology, Srimati Kannuri Santhamma Centre for Vitreo-Retinal Diseases, Anant Bajaj Retina Institute, L V Prasad Eye Institute, Banjara Hills, Hyderabad 500034, India. rpk@lvpei.org
Received: March 30, 2026 Revised: May 13, 2026 Accepted: June 23, 2026 Published online: July 26, 2026 Processing time: 117 Days and 21.2 Hours
Core Tip
Core Tip: Silicone oil-induced glaucoma is a challenging secondary glaucoma with limited surgical options, particularly in eyes with preserved visual potential. This study evaluated limited transscleral cyclophotocoagulation (TSCPC) as a minimally invasive treatment approach in this subset of patients. Limited TSCPC provided moderate intraocular pressure control, reduced anti-glaucoma medication burden, and preserved visual acuity in most eyes, with a favorable safety profile. However, the need for repeat interventions underscores the refractory nature of the disease. Limited TSCPC may represent a useful adjunctive treatment option when conventional surgical approaches are not feasible and warrants further evaluation in larger controlled studies.
